Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in children

Medical and Pediatric Oncology

Volumn 26, Issue 6, 1996, Pages 380-386

  Saarinen, Ulla M ^a   Hovi, Liisa ^a   Juvonen, Eeva ^a   Riikonen, Pekka ^a   Möttönen, Merja ^a   Mäkipernaa, Anne ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

allogeneic bone marrow transplantation; autologous bone marrow transplantation; G CSF; myeloid engraftment

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; INFECTIOUS COMPLICATION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BLOOD PLATELETS; BONE MARROW; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; INJECTIONS, SUBCUTANEOUS; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PILOT PROJECTS; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 0029879392     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199606)26:6<380::AID-MPO2>3.0.CO;2-D     Document Type: Article

References (39)

1. Riikonen P: Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 10:918-923, 1991.
2. Riikonen P, Saarinen UM, Mäkipernaa A, et al.: Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: A double-blind placebo-controlled study in children. Pediatr Infect Dis J 13:197-202, 1994.
3. Saarinen UM, Kekomäki R, Siimes MA, Myllylä G: Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 75:512-517, 1990.
4. Saarinen UM, Koskimies S, Myllyla G: Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused children with cancer. Vox Sang 65:286-292, 1993.
5. Aurer I, Ribas A, Gale RP: What is the role of recombinant colony stimulating factors in bone marrow transplantation? Bone Marrow Transplant 6:79-87, 1990.
6. Mertelsmann R, Herrmann F, Hecht T, Schultz G: Hematopoietic growth factors in bone marrow transplantation. Bone Marrow Transplant 6:73-77, 1990.
7. Appelbaum FR: The use of colony stimulating factors in marrow transplantation. Cancer 72:3387-3392, 1993.
8. Singer JW: Use of recombinant hematopoietic growth factors in bone marrow transplantation. Am J Pediatr Hematol Oncol 15: 175-184, 1993.
9. Nemunaitis J, Rabinowe SN, Singer JW, et al.: Recombinant granuloeyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773-1778, 1991.
10. Advani R, Chao NJ, Horning SJ, et al.: Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Ann Intern Med 116:182-189, 1992.
11. Link H, Boogaerts M, Carella A, et al.: Recombinant human granulocyte-macrophage colony stimulating factor (RH-GM-CSF) after autologous bone marrow transplantation for acute lymphoblastic leukemia and non-Hodgkin's-lymphoma: A randomized double blind multicenter trial in Europe (abstract). Blood 76:152a, 1990.
12. Gorin NC, Coiffer B, Pico J, et al.: Granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens aplasia duration after autologous bone marrow transplantation (ABMT) in non-Hodgkin's lymphoma: A randomized placebo-controlled double-blind study (abstract). Blood 76:542a, 1990
13. Khwaja A, Linch DC, Goldstone AH, et al.: Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: A British National Lymphoma Investigation double-blind, placebocontrolled trial. Br J Haematol 82:317-323, 1992.
14. Taylor KM, Jagannath S, Spitzer G, et al.: Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high- dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 7:1791-1799, 1989.
15. Sheridan WP, Morstyn G, Wolf M, et al.: Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895, 1989.
16. Peters WP, Kurtzberg J, Atwater S, et al.: Comparative effects of rHuG-CSF and rHuGM-CSF on hematopoietic reconstitution and granulocyte function following high dose chemotherapy and autologous bone marrow transplantation (abstract). Proc Am Soc Clin Oncol 8:181, 1989.
17. Khwaja A, Mills W, Leveridge K, Goldstone AH, Linch DC: Efficacy of delayed granulocyte colony-stimulating factor after autologous BMT. Bone Marrow Transplant 11:479-482, 1993.
18. Stahel RA, Muller E, Pichert G, et al.: Dose intensification with autologous marrow support in high risk lymphoma: Acceleration of hematopoietic recovery and reduction of days of hospitalization with granulocyte colony- stimulating factor (G-CSF) in a randomized open-label trial (abstract). Proc Am Soc Clin Oncol 11:321, 1992.
19. Biaise D, Vernant JP, Fiere D, et al.: A randomised, controlled, multicenter trial of recombinant human granulocyte colony stimulating factor (filgrastim) in patients treated by bone marrow transplantation (BMT) with total body irradiation (TBI) for acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) (abstract). Blood 80:248a, 1992.
20. Linch DC, Scarffe H, Proctor S, et al.: Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant 11:307-311, 1993.
21. Powles R, Smith C, Milan S, et al.: Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: Double-blind, placebo- controlled trial. Lancet 2:1417-1420, 1990.
22. Nemunaitis J, Buckner CD, Applebaum FR, et al.: Phase I-II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 77:2065-2071, 1991.
23. De Witte T, Gratwohl A, Van Der Lely N, et al.: Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood 79:1359-1365, 1992.
24. Nemunaitis J, Anasetti C, Storb R, et al.: Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 79:2572-2577, 1992.
25. Teshima H, Ishtkawa J, Kitayama H, et al.: Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: A phase I/II study. Exp Hematol 17:853-858, 1989.
26. Masaoka T, Takaku F, Kato S, et al.: Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Exp Hematol 17.1047-1050, 1989.
27. Kodo H, Asano S: Phase II study of rhG-CSF in bone marrowtransplanted patients (abstract). Exp Hematol 17:711, 1989.
28. Kitayama H, Ishikawa J, Yamagami T, et al.: Granulocyte colony-stimulating factor in allogeneic bone marrow transplantation. Jpn J Clin Oncol 19:367-372, 1989.
29. Phillip T, Michon J, Bernard JL, et al.: Double-blind study of safety and efficacy of GM-CSF-Sandoz given intravenously for 14 days in patients with neuroblastoma after autologous BMT compared to intravenous infusion of placebo (abstract). Exp Hematol 17:658, 1989.
30. Nemunaitis JJ: RhGM-CSF in bone marrow transplantation: Experience in pediatric patients. Med Pediatr Oncol Suppl 2:31-33, 1992.
31. Saarinen UM, Hovi L, Riikonen P, Pihkala J, Juvonen E: Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy-induced neutropenia. Med Pediatr Oncol 20:489-496, 1992.
32. Weinthal J, Sender L, Briones G, Gillan E, Cairo MS: Sequential GM-CSF/G-CSF compared to GM-CSF alone significantly accelerates myeloid engraftment following bone marrow transplantation (BMT) (abstract). Proc Am Assoc Cancer Res 34:217, 1993.
33. Guinan EC, Sieff CA, Oette DH, Nathan DG: A phase I-II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76:1077-1082, 1990.
34. Furman WL, Fairclough DL, Huhn RD, et al.: Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony- stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. J Clin Oncol 9:1022-1028, 1991.
35. Saarinen UM, Lähteenoja KM, Juvonen E: Bone marrow fractionation by the Haemonetics system: Reduction of red cell mass before marrow freezing, with special reference to pediatric marrow volumes. Vox Sang 63:16-22, 1992.
36. Saarinen UM, Sariola H, Hovi L: Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue. Am J Pediatr Hematol Oncol 13:315-319, 1991.
37. Guilbert LJ, Iscove NN: Partial replacement of serum by selenite, transferrin, albumin and lecithin in hematopoietic cell culture. Nature 263:594-595, 1976.
38. Saarinen UM, Hovi L, Viinikka L, Juvonen E, Myllylä G: Reemphasis on leukocyte transfusions: Induction of myeloid marrow recovery in critically ill, neutropenic children with cancer. Vox Sang 68:90-99, 1995.
39. Nemunaitis J, Singer JW, Buckner CD, et al.: Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood 76:245-253, 1990.